Hypofractionated stereotactic body radiotherapy in low- and intermediate-risk prostate carcinoma

PURPOSE: Stereotactic body radiotherapy (SBRT) takes advantage of low α/β ratio of prostate cancer to deliver a large dose in few fractions. We examined clinical outcomes of SBRT using CyberKnife for the treatment of low- and intermediate-risk prostate cancer. MATERIALS AND METHODS: This study was b...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hun Jung, Phak, Jeong Hoon, Kim, Woo Chul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Radiation Oncology 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5207371/
https://www.ncbi.nlm.nih.gov/pubmed/27306777
http://dx.doi.org/10.3857/roj.2015.01571

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5207371/
https://www.ncbi.nlm.nih.gov/pubmed/27306777
http://dx.doi.org/10.3857/roj.2015.01571

Ejemplares similares